Document Detail

Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.
MedLine Citation:
PMID:  24072770     Owner:  NLM     Status:  In-Data-Review    
The purpose of this European Heart Rhythm Association (EHRA) survey was to assess clinical practice in relation to stroke prevention in atrial fibrillation (AF), particularly into the use of novel oral anticoagulants (NOACs) for stroke prevention, among members of the EHRA electrophysiology (EP) research network. In this EP Wire survey, we have provided some insights into current practice in Europe for the use of NOACs for stroke prevention in AF. There were clear practice differences evident, and also the need for greater adherence to the guidelines, especially since guideline adherent management results in better outcomes in AF.
Gregory Y H Lip; Maria Grazia Bongiorni; Dan Dobreanu; Thorsten Lewalter; Jesper Hastrup Svendsen; Carina Blomström-Lundqvist;
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology     Volume:  15     ISSN:  1532-2092     ISO Abbreviation:  Europace     Publication Date:  2013 Oct 
Date Detail:
Created Date:  2013-09-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883649     Medline TA:  Europace     Country:  England    
Other Details:
Languages:  eng     Pagination:  1526-32     Citation Subset:  IM    
University of Birmingham Centre for Cardiovascular Sciences, City Hospital Birmingham, Birmingham B18 7DH, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Native valve endocarditis caused by Erysipelothrix rhusiopathiae in an immunocompetent individual.
Next Document:  Oral administration of naturally occurring chitosan based nanoformulated green tea polyphenol EGCG e...